быстрая доставка ~4 недели
Размер
- 100 μg
- 1000 μg
- 500 μg
Recombinant Human TNFSF8/CD30 Ligand Protein (RP02044)
- Описание
-
Overview
Product name Recombinant Human TNFSF8/CD30 Ligand Protein Catalog No. RP02044 Description Recombinant Human IL-13 R alpha 1 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Gln63-Asp234) of human CD30 Ligand/TNFSF8 (Accession #P32971-1) fused with an Fc at the N-terminus. Bio-Activity Immobilized Biotinylated Human CD30 at 0.2 μg/mL (100 μL/well), dose response curve for Human CD30 Ligand with the EC50 of 59.9 ng/mL determined by ELISA. Purity > 95% by SDS-PAGE. Endotoxin < 0.1 EU/μg of the protein by LAL method. Formulation Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. Species Human Background
CD30 ligand (CD30L)/TNFSF8 is a type II membrane protein belonging to the TNF superfamily. CD30L is expressed on the cell surface of activated T cells, B cells, and monocytes. The protein is also constitutively expressed on granulocytes and medullary thymic epithelial cells.CD30L is a cytokine that binds to TNFRSF8/CD30. Induces proliferation of T-cells.Product information
Synonym CD153; CD30L; CD30LG; TNLG3A Expression Host HEK293 cells Tag N-mFc Swiss-Prot Gene ID Usage guide
Storage Store the lyophilized protein at -20°C to -80 °C for long term.
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.Reconstitution Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. * For research use only. Not for therapeutic or diagnostic purposes.
Product Protocols







